Delivery Order SPE2DB22D9316-SPE2DB25FYN86
Award Date
4/21/25
Potential Completion Date
5/12/25
Potential Value
$41K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide 4,564,751,606 units of Keytruda 100 mg/4 mL vial. The firm-fixed-price contract, valued at $80,218.40, runs through June 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which was awarded by the DLA to fulfill the recurring...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,469,465 units of the pharmaceutical product KEYTRUDA 100 MG/4 ML VIAL 4ML. The contract has a completion date of February 12, 2024 and a potential value of $80,218.40. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide various pharmaceutical and medical supplies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the woman-owned small business DMS Pharmaceutical Group Inc. for the delivery of Keytruda 100 mg/4 ml vial. The firm fixed-price contract, valued at $32,087.36, has a completion date of June 11, 2024. The contract is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award, valued at $77,505.20, is for the procurement of Keytruda 100 mg/4 ml vial (4 ml) to support the medical supply needs of military healthcare facilities. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $98,449.80 contract is for the supply of 4,567,668,769 units of the drug Keytruda 100 mg/4 ml vial. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to acquire a wide range of pharmaceutical products, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,142.85 firm fixed-price contract is for the supply of Keytruda 100 mg/4 ml vial. The contract has an ultimate completion date of July 3, 2024. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) Medical Supply Chain division. The $80,285.70 contract is for the delivery of Keytruda 100 mg/4 ml vials to support the recurring pharmaceutical needs of military health facilities. This order is placed under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Keytruda 100 mg/4 ml vial. The contract has a potential value of $48,171.42 and a completion date of February 27, 2024. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDV) with DLA, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Keytruda 100 mg/4 ml vials. The order was placed under an existing indefinite delivery contract that DMS Pharmaceutical Group holds with DLA to supply a variety of pharmaceutical and medical products to military treatment facilities globally. The delivery order has a potential value of $116,257.80 and is scheduled for completion on...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,109.20 firm fixed price contract is for the supply of Keytruda 100 mg/4 ml vial, a branded oncology medication. The delivery order is part of a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive...